What's new in critical illness and injury science? An evidence-based analysis of the impact of Janus Kinase inhibitors on 28-day mortality in patients admitted with COVID-19
Int J Crit Illn Inj Sci
.
2021 Jul-Sep;11(3):109-111.
doi: 10.4103/ijciis.ijciis_80_21.
Epub 2021 Sep 25.
Authors
Andrew C Miller
1
,
Yannick A D'Silva
2
Affiliations
1
Department of Emergency Medicine, Alton Memorial Hospital, Alton, IL, USA.
2
Department of Internal Medicine, Rhode Island Hospital and Miriam Hospital, Warren Alpert Medical School of Brown University, Providence, RI, USA.
PMID:
34760655
PMCID:
PMC8547681
DOI:
10.4103/ijciis.ijciis_80_21
No abstract available
Publication types
Editorial